Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Trial

In trial, Eli Lilly’s weight loss drug reduces risk of diabetes development

August 20, 2024
Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Are you tired of struggling with weight loss and the risk of developing Type 2 diabetes? Well, you’re not alone. But here at Extreme Investor Network, we bring you the latest groundbreaking news in the … Read more

Categories Business News Tags development, diabetes, drug, Eli, Lillys, loss, reduces, risk, Trial, weight

Viking Therapeutics stock soars following announcement of weight loss injection trial preparations

July 25, 2024
Viking Therapeutics stock jumps on weight loss injection trial plans

Are you looking for the next big investment opportunity in the biotech sector? Look no further than Viking Therapeutics, whose stock skyrocketed more than 30% after announcing plans to fast-track their experimental weight loss injection … Read more

Categories Business News Tags Announcement, injection, loss, preparations, Soars, stock, Therapeutics, Trial, Viking, weight

Late-stage trial of Pfizer’s gene therapy proves successful in treating hemophilia A

July 24, 2024
Pfizer's gene therapy for hemophilia A succeeds in late-stage trial

Revolutionizing Treatment for Hemophilia A: Pfizer’s Breakthrough Gene Therapy Kena Betancur | Corbis News | Getty Images At Extreme Investor Network, we are excited to share the latest groundbreaking news in the field of gene … Read more

Categories Business News Tags Gene, hemophilia, latestage, Pfizers, proves, successful, Therapy, treating, Trial

Successful Phase 3 Trial of Gilead’s PrEP Lenacapavir

June 20, 2024
Gilead PrEP lenacapavir succeeds in Phase 3 trial

Introducing Groundbreaking HIV Prevention Technology: Gilead’s Lenacapavir Shot Gilead recently made a groundbreaking announcement that has the potential to revolutionize HIV prevention. Their experimental twice-yearly medicine, lenacapavir, was shown to be 100% effective in preventing … Read more

Categories Business News Tags Gileads, Lenacapavir, Phase, PrEP, successful, Trial

Results from late-stage trial indicate Moderna combination Covid and flu vaccine is effective

June 10, 2024
Moderna combination Covid, flu vaccine shows positive late-stage data

At Extreme Investor Network, we bring you the latest and most cutting-edge insights in the business world. Today, we are thrilled to share some groundbreaking news from Moderna, one of the leading biotech companies in … Read more

Categories Business News Tags combination, covid, Effective, Flu, latestage, Moderna, results, Trial, Vaccine

Trial shows enhanced survival with Moderna and Merck cancer vaccine in combination with Keytruda

June 3, 2024
Moderna, Merck cancer vaccine with Keytruda improved survival in trial

## Breaking News: Moderna and Merck Released Positive Three-Year Data on Experimental Cancer Vaccine ## Moderna and Merck made headlines again with the release of more positive three-year data on their experimental vaccine, which was … Read more

Categories Business News Tags Cancer, combination, Enhanced, Keytruda, Merck, Moderna, shows, survival, Trial, Vaccine

Positive long-term trial results of Pfizer’s lung cancer drug suggest effectiveness

May 31, 2024
Pfizer lung cancer drug shows promising long-term trial results

When it comes to advancements in cancer treatment, Pfizer is making headlines with its drug Lorbrena. This medication has shown promising long-term results in a late-stage trial for an advanced form of lung cancer, setting … Read more

Categories Business News Tags Cancer, drug, effectiveness, longterm, lung, Pfizers, Positive, results, suggest, Trial

Stock of DJT plummets by 8% following Trump’s conviction in hush money trial

May 30, 2024
DJT stock drops 8% after Trump found guilty in hush money trial

Welcome to Extreme Investor Network, where we bring you the latest updates and insights on the world of finance. Today, we dive into the recent developments surrounding Trump Media & Technology Group (DJT) and its … Read more

Categories Finance Tags conviction, DJT, hush, money, Plummets, stock, Trial, Trumps

Early trial of Roche weight loss drug demonstrates encouraging results

May 17, 2024
Roche weight loss drug shows promising results in early trial

Are you looking for the latest news in the business world? Well, look no further because Roche, a leading pharmaceutical company, has made headlines with its new experimental weight loss drug, CT-388. In a recent … Read more

Categories Business News Tags Demonstrates, drug, early, encouraging, loss, results, Roche, Trial, weight

Only Congress Has the Authority to Put Trump on Trial, Not the Department of Justice

April 27, 2024
We Trump Can Only Be Put On Trial By Congress - Not The Department Of Justice

Title: Understanding the Legal Immunity Claims of President Trump Are you curious about the legal immunity claims of former President Donald Trump? At Extreme Investor Network, we dive deep into the geopolitical and practical implications … Read more

Categories Economy Tags Authority, Congress, Department, Justice, put, Trial, Trump
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

Categories

Recent Posts

  • Ulli Schulz Explores the Evolution of 3D Design in Conversation with Render NetworkJune 13, 2025
  • Kenvue Considers Divesting Certain Skin Health and Beauty Brands, Sources ReportJune 13, 2025
  • Natural Gas Price Outlook: Stabilizes at Crucial Moving Average SupportJune 13, 2025
  • Carter Worth’s Insights on the Future Movements of Oil Prices According to the ChartsJune 13, 2025
  • Character.AI Unveils Framework for Assessing Engaging Writing ModelsJune 13, 2025
  • Analysis: Trump’s Tax Cut Bill May Hinder U.S. Critical Minerals ProjectsJune 13, 2025
  • Gold Price Outlook: Bullish Momentum and Patterns Point to New HighsJune 13, 2025
  • JBS Brazilian Meat Company Launches IPO in the U.S.June 13, 2025
  • Bank of America: S&P 500 Overvalued Across All 20 Metrics It MonitorsJune 13, 2025
  • Market Insights – June 13, 2025June 13, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights